Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Fetal Cardiac Intervention for Pulmonary Atresia with Intact Ventricular Septum: International Fetal Cardiac Intervention Registry.

PMID: 32634804
Journal: FETAL DIAGNOSIS AND THERAPY
Year: 2020
Reference: Fetal Diagn Ther. 2020 Jul 7:1-9. doi: 10.1159/000508045.
Impact factor:
Publication type: Paper in international publication
Authors: Armstrong, Aimee; Dangel, Joanna; Devlieger, Roland; Ferrer, Queralt; Frommelt, Michele; Galindo, Alberto; Gardiner, Helena; Gelehrter, Sarah; Grinenco, Sofia; Herberg, Ulrike et al.
DOI: 10.1159/000508045

Fetal Transient Skin Edema in Two Pregnant Women With Coronavirus Disease 2019 (COVID-19).

PMID: 32649505
Journal: OBSTETRICS AND GYNECOLOGY
Year: 2020
Reference: Obstet Gynecol. 2020 Nov;136(5):1016-1020. doi: 10.1097/AOG.0000000000004059.
Impact factor: 5.524
Publication type: Paper in international publication
Authors: Garcia-Manau, Pablo, Garcia-Ruiz, Itziar, Rodo, Carlota, Sulleiro, Elena, Maiz, Nerea, Catalan, Marina, Fernandez-Hidalgo, Nuria, Balcells, Joan, Anton, Andres, Carreras, Elena et al.
DOI: 10.1097/AOG.0000000000004059

Fetal Transient Skin Edema in Two Pregnant Women With Coronavirus Disease 2019 (COVID-19).

PMID: 32649505
Journal: OBSTETRICS AND GYNECOLOGY
Year: 2020
Reference: Obstet Gynecol. 2020 Nov;136(5):1016-1020. doi: 10.1097/AOG.0000000000004059.
Impact factor:
Publication type: Paper in international publication
Authors: Anton, Andres; Balcells, Joan; Carreras, Elena; Catalan, Marina; Fernandez-Hidalgo, Nuria; Garcia-Manau, Pablo; Garcia-Ruiz, Itziar; Maiz, Nerea; Rodo, Carlota; Sulleiro, Elena et al.
DOI: 10.1097/AOG.0000000000004059

FHLdb: A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis.

PMID: 32076423
Journal: Frontiers in Immunology
Year: 2020
Reference: Front Immunol. 2020 Jan 31;11:107. doi: 10.3389/fimmu.2020.00107. eCollection 2020.
Impact factor: 5.085
Publication type: Paper in international publication
Authors: Vinas-Gimenez, Laura, Padilla, Natalia, Batlle-Maso, Laura, Casals, Ferran, Riviere, Jacques G, Martinez-Gallo, Monica, de la Cruz, Xavier, Colobran, Roger et al.
DOI: 10.3389/fimmu.2020.00107

FHLdb: A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis.

PMID: 32076423
Journal: Frontiers in Immunology
Year: 2020
Reference: Front Immunol. 2020 Jan 31;11:107. doi: 10.3389/fimmu.2020.00107. eCollection 2020.
Impact factor:
Publication type: Paper in international publication
Authors: Batlle-Maso, Laura; Casals, Ferran; Colobran, Roger; de la Cruz, Xavier; Martinez-Gallo, Monica; Padilla, Natalia; Riviere, Jacques G; Vinas-Gimenez, Laura et al.
DOI: 10.3389/fimmu.2020.00107

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.

PMID: 32677452
Journal: Future Oncology
Year: 2020
Reference: Future Oncol. 2020 Oct;16(30):2385-2399. doi: 10.2217/fon-2020-0429. Epub 2020 Jul 17.
Impact factor: 2.66
Publication type: Paper in international publication
Authors: Macarulla, Teresa, Bridgewater, John, Wasan, Harpreet, Borad, Mitesh J, Abou-Alfa, Ghassan K, Jiang, Ping, Lihou, Christine F, Zhen, Huiling, Asatiani, Ekaterine, Feliz, Luis et al.
DOI: 10.2217/fon-2020-0429

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.

PMID: 32677452
Journal: Future Oncology
Year: 2020
Reference: Future Oncol. 2020 Oct;16(30):2385-2399. doi: 10.2217/fon-2020-0429. Epub 2020 Jul 17.
Impact factor:
Publication type: Paper in international publication
Authors: Abou-Alfa, Ghassan K; Asatiani, Ekaterine; Bekaii-Saab, Tanios S; Borad, Mitesh J; Bridgewater, John; Cutsem, Eric Van; Feliz, Luis; Furuse, Junji; Ioka, Tatsuya; Jiang, Ping et al.
DOI: 10.2217/fon-2020-0429

Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.

PMID: 32565133
Journal: Clinical Genitourinary Cancer
Year: 2020
Reference: Clin Genitourin Cancer. 2020 Dec;18(6):452-460. doi: 10.1016/j.clgc.2020.05.004. Epub 2020 May 11.
Impact factor: 2.695
Publication type: Paper in international publication
Authors: Ostiategui, Mar Llorente, Milagro, Nuria Lainez, Gonzalez-Del-Alba, Aranzazu, Gonzalez, Begona Mellado, Diaz, Enrique Gallardo, Gauna, Daniel Castellano, Santasusana, Montserrat Domenech, Herranz, Urbano Anido, Del Muro Solans, Xavier Garcia, Perez-Gracia, Jose Luis et al.
DOI: 10.1016/j.clgc.2020.05.004

Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.

PMID: 32565133
Journal: Clinical Genitourinary Cancer
Year: 2020
Reference: Clin Genitourin Cancer. 2020 Dec;18(6):452-460. doi: 10.1016/j.clgc.2020.05.004. Epub 2020 May 11.
Impact factor:
Publication type: Paper in international publication
Authors: Arranz Arija, Jose Angel; Bellmunt Molins, Joaquim; Climent Duran, Miguel Angel; Del Muro Solans, Xavier Garcia; Diaz, Enrique Gallardo; Garcia-Donas Jimenez, Jesus; Gauna, Daniel Castellano; Gonzalez, Begona Mellado; Gonzalez-Del-Alba, Aranzazu; Hernando-Polo, Susana et al.
DOI: 10.1016/j.clgc.2020.05.004

Final Overall Survival, Other Efficacy and Safety Results from ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged Non-Small-Cell Lung Cancer.

PMID: 31778798
Journal: Journal of Thoracic Oncology
Year: 2020
Reference: J Thorac Oncol. 2020 Apr;15(4):609-617. doi: 10.1016/j.jtho.2019.11.006. Epub 2019 Nov 25.
Impact factor: 13.357
Publication type: Paper in international publication
Authors: Nishio, Makoto, Felip, Enriqueta, Orlov, Sergey, Park, Keunchil, Yu, Chong-Jen, Tsai, Chun-Ming, Cobo, Manuel, McKeage, Mark, Su, Wu-Chou, Mok, Tony et al.
DOI: 10.1016/j.jtho.2019.11.006

Final Overall Survival, Other Efficacy and Safety Results from ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged Non-Small-Cell Lung Cancer.

PMID: 31778798
Journal: Journal of Thoracic Oncology
Year: 2020
Reference: J Thorac Oncol. 2020 Apr;15(4):609-617. doi: 10.1016/j.jtho.2019.11.006. Epub 2019 Nov 25.
Impact factor:
Publication type: Paper in international publication
Authors: Chen, Zhe; Cobo, Manuel; Felip, Enriqueta; McKeage, Mark; Mok, Tony; Nishio, Makoto; Orlov, Sergey; Park, Keunchil; Passos, Vanessa Q; Scagliotti, Giorgio V et al.
DOI: 10.1016/j.jtho.2019.11.006

Final-year nursing students called to work: Experiences of a rushed labour insertion during the COVID-19 pandemic.

PMID: 33217641
Journal: Nurse Education in Practice
Year: 2020
Reference: Nurse Educ Pract. 2020 Nov;49:102920. doi: 10.1016/j.nepr.2020.102920. Epub 2020 Nov 10.
Impact factor:
Publication type: Paper in international publication
Authors: Aguayo-Gonzalez, Mariela; Gomez-Ibanez, Rebeca; Granel, Nina; Leyva-Moral, Juan Manuel; Watson, Carolina et al.
DOI: 10.1016/j.nepr.2020.102920

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

PMID: 31911677
Journal: NATURE GENETICS
Year: 2020
Reference: Nat Genet. 2020 Jan;52(1):56-73. doi: 10.1038/s41588-019-0537-1. Epub 2020 Jan 7.
Impact factor: 27.603
Publication type: Paper in international publication
Authors: Camp, Nicola J, Fachal, Laura, Aschard, Hugues, Beesley, Jonathan, Barnes, Daniel R, Allen, Jamie, Kar, Siddhartha, Pooley, Karen A, Dennis, Joe, Michailidou, Kyriaki et al.
DOI: 10.1038/s41588-019-0537-1

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

PMID: 31911677
Journal: NATURE GENETICS
Year: 2020
Reference: Nat Genet. 2020 Jan;52(1):56-73. doi: 10.1038/s41588-019-0537-1. Epub 2020 Jan 7.
Impact factor:
Publication type: Paper in international publication
Authors: Aalfs, Cora; Adank, Muriel; Adlard, Julian; Agata, Simona; Ahmed, Munaza; Aittomaki, Kristiina; Allen, Jamie; Alonso, M Rosario; Amor, David; Andrews, Leslie et al.
DOI: 10.1038/s41588-019-0537-1

First Molecular Diagnosis of Clinical Cases of Gastric Anisakiosis in Spain.

PMID: 32331208
Journal: Genes
Year: 2020
Reference: Genes (Basel). 2020 Apr 22;11(4). pii: genes11040452. doi: 10.3390/genes11040452.
Impact factor: 3.759
Publication type: Paper in international publication
Authors: Alcover, M Magdalena, Godinez-Gonzalez, Carla, Gonzalez-Moreno, Olga, Masachs, Miquel, Fisa, Roser, Montoliu, Isabel, Roca-Gerones, Xavier et al.
DOI: 10.3390/genes11040452

First Molecular Diagnosis of Clinical Cases of Gastric Anisakiosis in Spain.

PMID: 32331208
Journal: Genes
Year: 2020
Reference: Genes (Basel). 2020 Apr 22;11(4). pii: genes11040452. doi: 10.3390/genes11040452.
Impact factor:
Publication type: Paper in international publication
Authors: Alcover, M Magdalena; Fisa, Roser; Godinez-Gonzalez, Carla; Gonzalez-Moreno, Olga; Masachs, Miquel; Montoliu, Isabel; Roca-Gerones, Xavier et al.
DOI: 10.3390/genes11040452

First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain.

PMID: 31987710
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2020
Reference: Enferm Infecc Microbiol Clin. 2020 Nov;38(9):410-416. doi: 10.1016/j.eimc.2019.11.008. Epub 2020 Jan 25.
Impact factor: 1.654
Publication type: Paper in national publication
Authors: Domingo-Garcia, Diego, Canton, Rafael, Gomez-Garcia de la Pedrosa, Elia, Aznar-Cano, Esteban, Leiva, Jose, Montes, Milagrosa, Sanchez-Romero, Isabel, Rodriguez-Diaz, Juan Carlos, Alarcon-Cavero, Teresa, Isabel Suarez Barrenechea, Ana et al.
DOI: 10.1016/j.eimc.2019.11.008

First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain.

PMID: 31987710
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2020
Reference: Enferm Infecc Microbiol Clin. 2020 Nov;38(9):410-416. doi: 10.1016/j.eimc.2019.11.008. Epub 2020 Jan 25.
Impact factor:
Publication type: Paper in national publication
Authors: Aguirre Bernat, Maria; Alarcon Cavero, Teresa; Alarcon-Cavero, Teresa; Alba Rubio, Claudio; Alba-Rubio, Claudio; Alonso Sanz, Mercedes; Alvarez Garcia, Patricia; Andrades Ortega, Maria; Angel Bratos Perez, Miguel; Arenal Andres, Noelia et al.
DOI: 10.1016/j.eimc.2019.11.008

[First universal newborn screening program for severe combined immunodeficiency in Europe. Three-years' experience in Catalonia.]

PMID: 33323927
Journal: Revista Espanola de Salud Publica
Year: 2020
Reference: Rev Esp Salud Publica. 2020 Dec 16;94.
Impact factor:
Publication type: Paper in national publication
Authors: Argudo Ramirez, Ana; Asso Ministral, Laia; Colobran, Roger; Fernandez Bardon, Rosa Maria; Garcia Villoria, Judit; Gonzalez de Aledo Castillo, Jose Manuel; Lopez Galera, Rosa Maria; Marin Soria, Jose Luis; Martin Nalda, Andrea; Martinez Gallo, Monica et al.
DOI:

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.

PMID: 32741971
Journal: BRITISH JOURNAL OF CANCER
Year: 2020
Reference: Br J Cancer. 2020 Oct;123(8):1235-1243. doi: 10.1038/s41416-020-1011-7. Epub 2020 Aug 3.
Impact factor: 5.791
Publication type: Paper in international publication
Authors: Aftimos, Philippe, Jungels, Christiane, Martin-Romano, Patricia, Rodon, Jordi, Kremer, Jill Dolores, Zhang, Wei, Bendell, Johanna, Hollebecque, Antoine, Martin-Liberal, Juan et al.
DOI: 10.1038/s41416-020-1011-7

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.

PMID: 32741971
Journal: BRITISH JOURNAL OF CANCER
Year: 2020
Reference: Br J Cancer. 2020 Oct;123(8):1235-1243. doi: 10.1038/s41416-020-1011-7. Epub 2020 Aug 3.
Impact factor:
Publication type: Paper in international publication
Authors: Aftimos, Philippe; Bendell, Johanna; Hollebecque, Antoine; Jungels, Christiane; Kremer, Jill Dolores; Martin-Liberal, Juan; Martin-Romano, Patricia; Rodon, Jordi; Zhang, Wei et al.
DOI: 10.1038/s41416-020-1011-7

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft.

PMID: 32304998
Journal: EBioMedicine
Year: 2020
Reference: EBioMedicine. 2020 Apr;54:102729. doi: 10.1016/j.ebiom.2020.102729. Epub 2020 Apr 15.
Impact factor: 5.736
Publication type: Paper in international publication
Authors: Coca, Maria Isabel, Reales, Laura, Camara-Rosell, Maria Luisa, Cediel, German, Coll, Ruth, Farre, Ramon, Navajas, Daniel, Vilarrodona, Anna, Garcia-Lopez, Joan, Munoz-Guijosa, Christian et al.
DOI: 10.1016/j.ebiom.2020.102729

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft.

PMID: 32304998
Journal: EBioMedicine
Year: 2020
Reference: EBioMedicine. 2020 Apr;54:102729. doi: 10.1016/j.ebiom.2020.102729. Epub 2020 Apr 15.
Impact factor:
Publication type: Paper in international publication
Authors: Agusti, Elba; Aylagas, Miriam; Bayes-Genis, Antoni; Camara-Rosell, Maria Luisa; Cediel, German; Coca, Maria Isabel; Coll, Ruth; Farre, Ramon; Galvez-Monton, Carolina; Garcia-Lopez, Joan et al.
DOI: 10.1016/j.ebiom.2020.102729

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.

PMID: 33052756
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2020
Reference: J Clin Oncol. 2020 Dec 20;38(36):4260-4273. doi: 10.1200/JCO.19.03250. Epub 2020 Oct 14.
Impact factor: 32.956
Publication type: Paper in international publication
Authors: Somervaille, Tim C P, Salamero, Olga, Montesinos, Pau, Willekens, Christophe, Perez-Simon, Jose Antonio, Pigneux, Arnaud, Recher, Christian, Popat, Rakesh, Carpio, Cecilia, Molinero, Cesar et al.
DOI: 10.1200/JCO.19.03250

Publications

Publications searcher

Fetal Cardiac Intervention for Pulmonary Atresia with Intact Ventricular Septum: International Fetal Cardiac Intervention Registry.

Fetal Transient Skin Edema in Two Pregnant Women With Coronavirus Disease 2019 (COVID-19).

Fetal Transient Skin Edema in Two Pregnant Women With Coronavirus Disease 2019 (COVID-19).

FHLdb: A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis.

FHLdb: A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis.

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.

Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.

Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.

Final Overall Survival, Other Efficacy and Safety Results from ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged Non-Small-Cell Lung Cancer.

Final Overall Survival, Other Efficacy and Safety Results from ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged Non-Small-Cell Lung Cancer.

Final-year nursing students called to work: Experiences of a rushed labour insertion during the COVID-19 pandemic.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

First Molecular Diagnosis of Clinical Cases of Gastric Anisakiosis in Spain.

First Molecular Diagnosis of Clinical Cases of Gastric Anisakiosis in Spain.

First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain.

First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain.

[First universal newborn screening program for severe combined immunodeficiency in Europe. Three-years' experience in Catalonia.]

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft.

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft.

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.

Patronage:

Collaborating:

Accreditations: